A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
Clinical trial NCT07083375 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07083375
- Sponsor
- Zhijie Wang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-06-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.